17 insiders reported 191 Form 4 transactions for Travere Therapeutics, Inc. (TVTX) over the past 18 months (most recent 2026-06-22). Recent activity: Inrig Jula (CHIEF MEDICAL OFFICER) Sell 468 shares, Coughlin Timothy (Director) Buy 10,000 shares, Baynes Roy D. (Director) Buy 4,500 shares, Baynes Roy D. (Director) Sell 4,500 shares, Coughlin Timothy (Director) Sell 10,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | 468 | $0 |
| 2026-06-16 | Coughlin Timothy | Director | Buy | 10,000 | $265,200 |
| 2026-06-16 | Baynes Roy D. | Director | Buy | 4,500 | $96,210 |
| 2026-06-16 | Baynes Roy D. | Director | Sell | 4,500 | $225,000 |
| 2026-06-16 | Coughlin Timothy | Director | Sell | 10,000 | $500,747 |
| 2026-05-21 | Coughlin Timothy | Director | Buy | 4,000 | $0 |
| 2026-05-21 | LYONS GARY A | Director | Buy | 4,000 | $0 |
| 2026-05-21 | Williams Brinkley Ruth | Director | Buy | 4,000 | $0 |
| 2026-05-21 | Squarer Ron | Director | Buy | 4,000 | $0 |
| 2026-05-21 | Orwin John A | Director | Buy | 4,000 | $0 |
| 2026-05-21 | Meckler Jeffrey A | Director | Buy | 4,000 | $0 |
| 2026-05-21 | Bruhn Suzanne Louise | Director | Buy | 4,000 | $0 |
| 2026-05-21 | Baynes Roy D. | Director | Buy | 4,000 | $0 |
| 2026-05-21 | Poole Sandra | Director | Buy | 4,000 | $0 |
| 2026-05-19 | Coughlin Timothy | Director | Sell | 3,250 | $141,342 |
| 2026-04-23 | ROTE WILLIAM E. | Chief Research Officer | Sell | 9,100 | $355,719 |
| 2026-04-16 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | 21,977 | $902,595 |
| 2026-04-16 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Buy | 2,500 | $56,000 |
| 2026-04-16 | Baynes Roy D. | Director | Buy | 8,000 | $143,520 |
| 2026-04-16 | LYONS GARY A | Director | Buy | 8,000 | $130,640 |
| 2026-04-16 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Buy | 6,250 | $55,812 |
| 2026-04-16 | Baynes Roy D. | Director | Buy | 9,000 | $138,870 |
| 2026-04-16 | LYONS GARY A | Director | Sell | 8,000 | $328,560 |
| 2026-04-16 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Buy | 6,500 | $132,990 |
| 2026-04-16 | Baynes Roy D. | Director | Buy | 4,500 | $82,215 |
Source: SEC Form 4 filings · as of 2026-06-22